Tamoxifen induced adenomyosis and adenomyomatous endometrial polyp
- 1 April 1993
- journal article
- case report
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 100 (4) , 386-388
- https://doi.org/10.1111/j.1471-0528.1993.tb12986.x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Potential Role of Tamoxifen in Prevention of Breast CancerJNCI Journal of the National Cancer Institute, 1991
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- TAMOXIFEN AND THE UTERUS AND ENDOMETRIUMThe Lancet, 1989
- ADJUVANT TAMOXIFEN IN EARLY BREAST CANCER: OCCURRENCE OF NEW PRIMARY CANCERSThe Lancet, 1989
- Non-genomic effects of estrogens and antiestrogensJournal of Steroid Biochemistry, 1988
- Nuclear localization of unoccupied oestrogen receptorsNature, 1984
- Monoclonal antibodies localize oestrogen receptor in the nuclei of target cellsNature, 1984
- Estrogen-Like Action of Tamoxifen on Vaginal Epithelium in Breast Cancer PatientsOncology, 1981
- Oestrogen-like effect of tamoxifen on vaginal epithelium.BMJ, 1977
- Progesterone antagonism of the oestrogen receptor and oestrogen-induced uterine growthNature, 1975